ArcticZymes
EU's Horizon 2020 Awards ArcticZymes €460K Grant
The Biotec Pharmacon subsidiary is taking part in the Virus-X EU Consortium by developing new viral enzymes and bringing them to the market.
ArcticZymes said last week that it has inked a supply agreement with GE Healthcare Life Sciences for products based on ArcticZymes' portfolio of heat-labile enzymes.